Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

212
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
212
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

301
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
301
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

331
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
331

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mediating effect of coping style between family resilience and demoralization in patients with decompensated cirrhosis.

Scientific reports·2026
Same author

Integrative subtyping by bile acid metabolism identifies <i>CLCA1</i>/<i>UGT2A3</i>/<i>ZG16</i> as markers of immune dysfunction and poor prognosis in colorectal cancer.

Frontiers in oncology·2026
Same author

Study on the correlation between Interleukin 4 and febrile seizures.

CytoJournal·2025
Same author

Family resilience and demoralization in decompensated cirrhosis: parallel mediation of psychological resilience and social support.

Frontiers in psychology·2025
Same author

An Assessment of Human-AI Interaction Capability in the Generative AI Era: The Influence of Critical Thinking.

Journal of Intelligence·2025
Same author

Voltage-Controlled Bimeron-Torques Switching of In-Plane Magnetization.

Physical review letters·2024

Related Experiment Video

Updated: Sep 11, 2025

Autonomous and Rechargeable Microneurostimulator Endoscopically Implantable into the Submucosa
08:17

Autonomous and Rechargeable Microneurostimulator Endoscopically Implantable into the Submucosa

Published on: September 27, 2018

8.6K

Biofeedback magnetic stimulation improves postoperative bowel dysfunction after rectal cancer surgery.

Yang Lin1, Gang Mao1, Jinghua Liang2

  • 1Department of Anorectal, Baoji Traditional Chinese Medicine Hospital No. 43 Baofu Road, Jintai District, Baoji 721000, Shaanxi, China.

American Journal of Translational Research
|August 18, 2025
PubMed
Summary

Biofeedback magnetic stimulation (BFMS) effectively manages postoperative bowel dysfunction after rectal cancer surgery. This treatment improves bowel function and quality of life, with anatomical factors predicting outcomes.

Keywords:
Rectal cancerbiofeedback magnetic stimulationinfluencing factorspostoperative bowel dysfunction

More Related Videos

Functional Assessment of Intestinal Motility and Gut Wall Inflammation in Rodents: Analyses in a Standardized Model of Intestinal Manipulation
09:44

Functional Assessment of Intestinal Motility and Gut Wall Inflammation in Rodents: Analyses in a Standardized Model of Intestinal Manipulation

Published on: September 11, 2012

22.3K
Breathing-controlled Electrical Stimulation BreEStim for Management of Neuropathic Pain and Spasticity
11:34

Breathing-controlled Electrical Stimulation BreEStim for Management of Neuropathic Pain and Spasticity

Published on: January 10, 2013

23.2K

Related Experiment Videos

Last Updated: Sep 11, 2025

Autonomous and Rechargeable Microneurostimulator Endoscopically Implantable into the Submucosa
08:17

Autonomous and Rechargeable Microneurostimulator Endoscopically Implantable into the Submucosa

Published on: September 27, 2018

8.6K
Functional Assessment of Intestinal Motility and Gut Wall Inflammation in Rodents: Analyses in a Standardized Model of Intestinal Manipulation
09:44

Functional Assessment of Intestinal Motility and Gut Wall Inflammation in Rodents: Analyses in a Standardized Model of Intestinal Manipulation

Published on: September 11, 2012

22.3K
Breathing-controlled Electrical Stimulation BreEStim for Management of Neuropathic Pain and Spasticity
11:34

Breathing-controlled Electrical Stimulation BreEStim for Management of Neuropathic Pain and Spasticity

Published on: January 10, 2013

23.2K

Area of Science:

  • Gastroenterology
  • Surgical Oncology
  • Rehabilitation Medicine

Background:

  • Postoperative bowel dysfunction (PBD) is a common complication following rectal cancer surgery.
  • Effective management strategies are crucial for improving patient outcomes and quality of life.

Purpose of the Study:

  • To assess the clinical efficacy of biofeedback magnetic stimulation (BFMS) for PBD after rectal cancer surgery.
  • To identify predictors of treatment success in managing PBD.

Main Methods:

  • A retrospective cohort study included 158 patients undergoing low anterior resection.
  • Patients received either BFMS (observation group, n=83) or conventional rehabilitation (control group, n=75).
  • Outcomes measured included defecation function, anorectal manometry, Wexner scores, and QLQ-CR29 quality-of-life scores.

Main Results:

  • The BFMS group demonstrated significantly improved defecation function, anorectal pressure, and quality of life at 2 and 3 months postoperatively (P<0.05).
  • Adverse reaction rates were similar between groups.
  • Multivariate analysis identified anastomotic leakage, ultra-low rectal cancer, interspinous diameter, and treatment method as independent predictors of outcomes (P<0.05).

Conclusions:

  • BFMS is a safe and effective therapy for PBD following rectal cancer surgery.
  • BFMS enhances bowel function and patient quality of life.
  • Anatomical and surgical factors are key predictors of treatment response.